Loading company…
Tendyne Holdings develops medical devices for structural heart disease, including mitral valve repair and replacement.
Founded in 2010 in Roseville, US, Tendyne Holdings makes devices for structural heart disease, including the Tendyne device for mitral valve replacement and Amplatzer devices for congenital heart defects, and sells them to healthcare providers and surgical centers. Abbott Laboratories acquired the company for USD 250 mn in September 2015. The company has completed 5 deals, with the most recent on September 8, 2015.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in